Actively Recruiting
Observational Study on Vitamin C-Injektopas® 7.5g in Patients With Vitamin C Deficiency Due to Acute and Chronic Diseases
Led by Pascoe Pharmazeutische Praeparate GmbH · Updated on 2025-05-21
1000
Participants Needed
1
Research Sites
43 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to learn more about vitamin C deficiency in patients with either acute or chronic diseases. It focuses on understanding how symptoms change over time and how well patients tolerate treatment. The study involves patients diagnosed with vitamin C deficiency either by lab tests or based on symptoms such as fatigue, infections, bleeding gums, joint pain, and poor wound healing. The study observes patients treated with Vitamin C Injektopas® 7.5 g, given for an expected average of about 3 weeks for acute diseases or 12 weeks for chronic diseases. Two groups are included: those with acute underlying diseases and those with chronic underlying diseases, both receiving this vitamin C therapy during the study period. Participants will be followed to assess changes in general and disease-specific symptoms, as well as treatment tolerability and overall effectiveness from the patient's perspective. Researchers will also record the number of vitamin C infusions and measure quality of life for chronic disease patients. The study duration ranges up to approximately 12 weeks, with evaluations at the last visit to understand symptom improvement and treatment impact.
CONDITIONS
Brief Title
A Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with vitamin C deficiency
- Age �3A 18 years
You will not qualify if you...
- Hypersensitivity to the active ingredient or any of the excipients
- Oxalate urolithiasis
- Iron storage disease (thalassemia, hemochromatosis, sideroblastic anemia) or recent red blood cell transfusion
- Renal insufficiency
- Glucose-6-phosphate dehydrogenase deficiency/defect
- Pregnant/breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to approximately 12 weeks depending on the underlying disease being acute or chronic
Participants are observed to document the use of Vitamin C Injektopas® 7.5g and assess changes in symptoms and treatment tolerability.
Trial Site Locations
Total: 1 location
1
Multiple Physicians from Austria
Vienna, Etc., Austria, Austria
Actively Recruiting
Research Team
J
Jennifer Brueckmann, CRA
B
Bianka B. Krick, CRA
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here